MXPA02008072A - Composicion farmaceutica. - Google Patents

Composicion farmaceutica.

Info

Publication number
MXPA02008072A
MXPA02008072A MXPA02008072A MXPA02008072A MXPA02008072A MX PA02008072 A MXPA02008072 A MX PA02008072A MX PA02008072 A MXPA02008072 A MX PA02008072A MX PA02008072 A MXPA02008072 A MX PA02008072A MX PA02008072 A MXPA02008072 A MX PA02008072A
Authority
MX
Mexico
Prior art keywords
membrane
nail
solvent
solution
permeation enhancer
Prior art date
Application number
MXPA02008072A
Other languages
English (en)
Spanish (es)
Inventor
Robert J Gyurik
Original Assignee
Bentley Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bentley Pharmaceuticals Inc filed Critical Bentley Pharmaceuticals Inc
Publication of MXPA02008072A publication Critical patent/MXPA02008072A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MXPA02008072A 2000-02-16 2001-02-16 Composicion farmaceutica. MXPA02008072A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18292400P 2000-02-16 2000-02-16
PCT/US2001/005302 WO2001060325A1 (en) 2000-02-16 2001-02-16 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
MXPA02008072A true MXPA02008072A (es) 2004-04-05

Family

ID=22670647

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02008072A MXPA02008072A (es) 2000-02-16 2001-02-16 Composicion farmaceutica.

Country Status (17)

Country Link
EP (1) EP1257248B1 (OSRAM)
JP (1) JP2005503318A (OSRAM)
KR (2) KR20080049148A (OSRAM)
CN (1) CN1422142A (OSRAM)
AT (1) ATE526917T1 (OSRAM)
AU (2) AU2001243189B2 (OSRAM)
BR (1) BR0108438A (OSRAM)
CA (1) CA2400178A1 (OSRAM)
HU (1) HUP0204555A3 (OSRAM)
MA (1) MA26883A1 (OSRAM)
MX (1) MXPA02008072A (OSRAM)
NO (1) NO20023866L (OSRAM)
NZ (1) NZ520749A (OSRAM)
PL (1) PL357111A1 (OSRAM)
TW (1) TWI232756B (OSRAM)
WO (1) WO2001060325A1 (OSRAM)
ZA (1) ZA200206553B (OSRAM)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
GB0203276D0 (en) * 2002-02-12 2002-03-27 Novartis Ag Organic compounds
JP2005538156A (ja) 2002-09-05 2005-12-15 ガルデルマ・ソシエテ・アノニム 爪塗布用溶液
EP1635770B1 (en) * 2003-03-21 2009-05-27 Nexmed Holdings, Inc. Antifungal nail coat and method of use
US8741333B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US8741332B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
JP5010125B2 (ja) * 2005-09-02 2012-08-29 有限会社日本健康科学研究センター 水虫治療用フィルム製剤
WO2007056068A2 (en) * 2005-11-02 2007-05-18 Bentley Pharmaceuticals, Inc. Macrocyclic formulations for transmembrane drug delivery
CA2633489C (en) * 2005-12-14 2013-09-24 Zars Pharma, Inc. Compositions and methods for treating dermatological conditions
JP5290582B2 (ja) * 2005-12-28 2013-09-18 帝國製薬株式会社 爪用医薬組成物
EP2112923A1 (en) 2007-01-22 2009-11-04 Targacept Inc. Intranasal, buccal, and sublingual administration of metanicotine analogs
ES2468540T3 (es) * 2009-02-13 2014-06-16 Topica Pharmaceuticals, Inc Formulación antif�ngica
EP2408299B1 (en) * 2009-03-20 2013-10-23 Stiefel Laboratories, Inc. Fatty acid monoglyceride compositions
GB201021386D0 (en) * 2010-12-16 2011-01-26 Burke Michael H A process for the manufacture of an antifungal nail lacquer
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
RS62297B1 (sr) 2011-11-23 2021-09-30 Therapeuticsmd Inc Prirodne kombinovane hormonske supstitucione formulacije i terapije
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
JP2017516768A (ja) 2014-05-22 2017-06-22 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然の併用ホルモン補充療法剤及び療法
KR101580077B1 (ko) 2015-03-28 2015-12-24 한국콜마주식회사 시크로피록스 함유 네일락카 조성물
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299826A (en) * 1979-10-12 1981-11-10 The Procter & Gamble Company Anti-acne composition
US5023252A (en) * 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US5731303A (en) * 1985-12-04 1998-03-24 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery compositions
DE3720147A1 (de) 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
EP0503312B1 (fr) * 1991-03-13 1997-01-08 Firmenich Sa Procédé de préparation de la 15-pentadécanolide ou de mélanges riches en cette macrolide
WO1996012467A1 (en) * 1994-10-20 1996-05-02 The Procter & Gamble Company Personal treatment compositions and/or cosmetic compositions containing enduring perfume
US5693828A (en) * 1996-05-09 1997-12-02 International Flavors & Fragrances Inc. Process for preparing lactones and intermediates therefor
US6224887B1 (en) * 1998-02-09 2001-05-01 Macrochem Corporation Antifungal nail lacquer and method using same
US6231875B1 (en) * 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
US6495124B1 (en) * 2000-02-14 2002-12-17 Macrochem Corporation Antifungal nail lacquer and method using same

Also Published As

Publication number Publication date
AU2001243189B2 (en) 2005-06-09
AU4318901A (en) 2001-08-27
BR0108438A (pt) 2003-04-01
EP1257248A1 (en) 2002-11-20
EP1257248A4 (en) 2007-10-03
EP1257248B1 (en) 2011-10-05
CA2400178A1 (en) 2001-08-23
HUP0204555A3 (en) 2004-06-28
TWI232756B (en) 2005-05-21
JP2005503318A (ja) 2005-02-03
ZA200206553B (en) 2003-11-17
ATE526917T1 (de) 2011-10-15
NO20023866D0 (no) 2002-08-15
HUP0204555A2 (en) 2003-05-28
WO2001060325A1 (en) 2001-08-23
NO20023866L (no) 2002-10-01
KR20030016227A (ko) 2003-02-26
MA26883A1 (fr) 2004-12-20
KR20080049148A (ko) 2008-06-03
PL357111A1 (en) 2004-07-12
NZ520749A (en) 2004-06-25
CN1422142A (zh) 2003-06-04

Similar Documents

Publication Publication Date Title
MXPA02008072A (es) Composicion farmaceutica.
CA2548897A1 (en) Endoparasiticidal agents for topical application
EA200000964A1 (ru) Жидкие полимерные композиции для регулируемого выделения биоактивных веществ
EP1369129A4 (en) ANTIDEPRESSOR REMEDIES CONTAINING AN EP1 ANTAGONIST AS ACTIVE INGREDIENT
TNSN04080A1 (en) Method and composition for improving fuel combustion
MY101536A (en) Anti-inflammatory and analgesic tape for external use
JP2005503318A5 (OSRAM)
GEP20033129B (en) Pressurised Metered Dose Inhalers and Aerosol Formulation
NZ504653A (en) Cosmetic compositions with dibenzylidene sorbitol and functionalized silicones
NO954957D0 (no) Synergistisk stabiliserte flytende enzymatiske blandinger
MY130857A (en) Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents
BR9505201A (pt) Agente de extração de tinta alcalino contendo álcool benzilico como em sistema solvente composição para extração de tinta e processos de preparação de um removedor de alcalino de revestimento ou emuls o água-em-óleo de agente de extração de tinta e de extrção de tinta de poliuterano sobre uma camada de primeira mão de epóxi sobre metal
ATE331544T1 (de) Gerät und verfahren zur aerosolisierung einer pharmazeutischen pulverzusammensetzung
NZ510469A (en) Injectable propofol formulations containing N-methyl pyrrolidone or 2-methyl pyrrolidone as a solvent
PL338335A1 (en) Pharmaceutic composition in the of self-emulsifiable formulation of lipophilic compounds
WO2001055092A3 (de) 5-aminolävulinsäure-formulierung in nichtwässrigen lösungsmitteln
EA200401625A1 (ru) Стабилизированные фармацевтические композиции на основе полиоксиэтилированного касторового масла и способ их получения
MXPA04000028A (es) Formulacion farmaceutica para la administracion intramuscular de fulvestrant.
KR880002524A (ko) 니코란딜 외용제
BR112021023276A2 (pt) Cartucho compreendendo nicotina e um solvente imiscível em água
ATE241412T1 (de) Verfahren zur extraktion mit einem überkritischen fluid
EP1245655A3 (en) Thermosetting coating composition and coating film forming method using the same
WO2001049273A3 (de) Pharmazeutische zusammensetzung zur transdermalen verabreichung von hormonen mit einem permeationsverbessernden zusatzstoff
ATE14437T1 (de) Aminoglycosid-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen und solche derivate zur verwendung als arzneimittel.
DK0773884T3 (da) Opløsningssystem til en flydende opløsning, der indeholder en aktiv ingrediens

Legal Events

Date Code Title Description
FA Abandonment or withdrawal